Drug profile · INN
umeclidinium bromide/ vilanterol trifenatate
ANORO ELLIPTA
umeclidinium bromide/ vilanterol trifenatate (ANORO ELLIPTA) is a muscarinic acetylcholine receptor m3 antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — umeclidinium bromide/ vilanterol trifenatate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
umeclidinium bromide/ vilanterol trifenatate (ANORO ELLIPTA) is a muscarinic acetylcholine receptor m3 antagonist.
Key facts
INN umeclidinium bromide/ vilanterol trifenatate
Brand ANORO ELLIPTA
Mechanism Muscarinic acetylcholine receptor M3 antagonist
Target Muscarinic acetylcholine receptor M3
Mechanism of action
Muscarinic acetylcholine receptor M3 antagonist
Primary target: Muscarinic acetylcholine receptor M3
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is umeclidinium bromide/ vilanterol trifenatate?
umeclidinium bromide/ vilanterol trifenatate (ANORO ELLIPTA) is a muscarinic acetylcholine receptor m3 antagonist.
What is the brand name for umeclidinium bromide/ vilanterol trifenatate?
ANORO ELLIPTA is a marketed brand name for umeclidinium bromide/ vilanterol trifenatate. Check FDA Drugs@FDA for the current US label holder and prescribing information.